Vizgen, Inc. filed a Form D with the Securities and Exchange Commission on 2025-10-07.
Vizgen, Inc. filed a Form D notice of an exempt securities offering with the SEC on October 7, 2025. The filing reports $3.50M sold. Its industry group is Biotechnology. It names Robert Carson (Executive Officer, Director), Simona Levi (Executive Officer), Matthew Posard (Director) (SEC Form D, October 7, 2025).
Is this your company?
Sell to companies like Vizgen, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-10-07 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Vizgen, Inc.
Free to see. No signup.
More on the people and the money behind Vizgen, Inc., from the filings we hold.
Biotechnology raises by companies based in Massachusetts, filed in October 2025, largest first.
Get an email when Vizgen, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Vizgen, Inc. raises, hires or launches. No email unless you switch it on.
Watch Vizgen, Inc. →Get the full cited report on Vizgen, Inc.
What the filing shows about Vizgen, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Vizgen, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Vizgen, Inc.'s address as 61 Moulton Street, Cambridge, MA 02138.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Vizgen, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Vizgen, Inc. is a registered filer with the SEC (CIK 1790415) and has filed since 2024-10-22. 3 filings are on record, the latest on 2026-01-12.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Vizgen, Inc.'s Form D of 2025-10-07 names Robert Carson, Simona Levi, Matthew Posard and 6 more as its officers, directors or promoters.
Its new offerings report $158.86M sold across 3 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
Explore the future of spatial biology with Vizgen’s multiomics platforms. Uncover cellular insights through spatial transcriptomics and proteomics.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Robert Carson is named as Executive Officer and Director on the Form D that Vizgen, Inc. filed with the SEC on 7 October 2025, one of 9 people that filing names.
Simona Levi is named as Executive Officer on the Form D that Vizgen, Inc. filed with the SEC on 7 October 2025, one of 9 people that filing names.
Matthew Posard is named as Director on the Form D that Vizgen, Inc. filed with the SEC on 7 October 2025, one of 9 people that filing names.
Terry Lo is named as Director on the Form D that Vizgen, Inc. filed with the SEC on 7 October 2025, one of 9 people that filing names.
Keith Crandell is named as Director on the Form D that Vizgen, Inc. filed with the SEC on 7 October 2025, one of 9 people that filing names.
Andrea Jackson is named as Director on the Form D that Vizgen, Inc. filed with the SEC on 7 October 2025, one of 9 people that filing names.
David Walt is named as Director on the Form D that Vizgen, Inc. filed with the SEC on 7 October 2025, one of 9 people that filing names.
Christian Urhich is named as Director on the Form D that Vizgen, Inc. filed with the SEC on 7 October 2025, one of 9 people that filing names.
Chris Guiffre is named as Executive Officer on the Form D that Vizgen, Inc. filed with the SEC on 7 October 2025, one of 9 people that filing names.
9 people named on the filing — 3 holding an executive role and 6 as directors only.
Named as of the 2025-10-07 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Vizgen, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Vizgen, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Vizgen, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Vizgen, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Vizgen, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-10-30 (vizgen.com).
Each opens in a new tab, filled in for Vizgen, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/vizgen-inc-form-d-25000001